Abstract
Introduction: The effects of empagliflozin on excitation-contraction coupling (ECC) have not been fully elucidated. We previously showed that empagliflozin directly reduces Ca 2+ /calmodulin kinase II (CaMKII) activity in human and murine heart failure, thereby improving contraction. Upon acute exposure, however, only subsarcolemmal [Na + ] is decreased, while [Na + ] cytosolic and [Ca 2+ ] cytosolic are only decreased after 24 h empagliflozin. Hypothesis: We hypothesize that empagliflozin reduces cardiac late Na current (late I Na ) via a reduction in CaMKII activity. We further hypothesize that Na + /Ca 2+ -exchanger (NCX) is acutely masking effects on cardiac [Na + ], thereby delaying downstream effects on cardiac ECC. Methods: Informed consent was obtained according to the Declaration of Helsinki. Human/murine cardiomyocytes (CM) were isolated and incubated with 1 μM empagliflozin for 30 min or 24 h. Some CM were treated with H 2 O 2 or ATX-II to induce late I Na . Whole-cell patch clamp was used to measure late I Na or I NCX . Epifluorescence with SBFI was used to obtain cardiac [Na + ]. Some CM were treated with NCX inhibitor KB-R7943 (5 μM). Results and Conclusions: Late I Na induced by H 2 O 2 was acutely inhibited in human and murine CM by empagliflozin, similar to CaMKII inhibition with AIP (2 μM). In CM lacking CaMKII or the CaMKII phosphosite S571 on Na V 1.5, no effect of empagliflozin on late I Na was present (also not under ATX-II stimulation). As shown before, subsarcolemmal [Na + ] estimated via patch clamp (Nernst equation) was already reduced after 30min (T30 min ). However, empagliflozin did not acutely reduce cytosolic [Na + ] at T30 min , but potently did so after 24h exposure (SBFI measurement). Acute inhibition of NCX with KB-R7943 showed no effect on cardiac Na + , but when performed in addition to empagliflozin, potently reduced [Na + ] already at T30 min . Matching this, NCX forward mode (patch clamp) was acutely induced by empagliflozin at T30 min , thus resulting in Na + influx that initially masks the reduction in [Na + ] resulting from a reduction in late I Na . This may explain why Na + /Ca 2+ homeostasis is only affected after 24h empagliflozin exposure. Our results may explain discrepant results on ECC by different groups on acute vs. prolonged empagliflozin exposure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.